Aprogen Medicines Inc. (KRX:007460)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2012
Hard Facing	-			13.41B	-	29.26B	32.30B
Insulation (Including NUKON)	-			2.74B	-	7.17B	6.90B
Steel Sales	-			19.42B	-	34.62B	10.28B
Medicines	59.41B			32.47B	-	50.80B	25.67B
Biosimilar Sales	-			9.39B	25.87B	-	-
Semiconductor	9.64B			-	-	-	-
Other	496.95M			769.50M	425.33M	2.77B	1.89B
Bio Sector	2.94B			-	-	-	-
Metal Sector	35.58B			-	-	-	-
Insulation Business Division	2.42B			-	-	-	-
Geothermal Construction	7.49B			-	-	-	-
Game	-			148.30M	-	2.52B	1.20B
Total	117.97B			78.35B	26.30B	127.14B	78.25B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2012
South Korea	111.80B			68.71B	479.85M	112.40B	-
Overseas	6.18B			9.63B	25.82B	12.02B	-
Other Areas	-			-	-	2.72B	-
Total	117.97B			78.35B	26.30B	127.14B	-

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error